Boston Properties, Inc. (BXP) has seen active transactions lately with several firms altering their stake, with Natixis Advisors L.P. buying 15783 shares, Russell Investments Group's holdings valued at $3.83 million, and Lincluden Management Ltd. acquiring 28,541 shares to name a few. The company's Q1 FFO have met estimates but the '24 view was lowered. They have also renewed their $600M ATM offering program as they buy out stakes of office portfolio partners. BXP is expanding by buying out 3 partners and entering into construction battles with a biotech firm over a Kendall Square site. Q4 earnings and revenues were higher than the '24 view, however, BXP's stock was downgraded to “Sell” at StockNews.com. The firm's resilience was evident from its Q1 2024 results. However, there are concerns whether the upward market trend witnessed by BXP, a 19% increase in 6 months, will last. Diversifying investments, BXP sold a 45% interest in its Kendall Square Life Science Properties reiterating its focus on office spaces while undergoing extensive renovation of a D.C.-Area Building.
Boston Properties BXP News Analytics from Wed, 02 Aug 2023 07:00:00 GMT to Sun, 12 May 2024 16:05:09 GMT -
Rating 6
- Innovation -3
- Information 8
- Rumor -5
